Does prazosin have any formulations with a dose lower than 1 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prazosin Availability Below 1 mg

No, prazosin does not come in a commercially available formulation lower than 1 mg in the United States. According to FDA labeling, prazosin capsules are manufactured in 1 mg, 2 mg, and 5 mg strengths only 1.

Standard Dosing Information

The FDA-approved initial dose of prazosin is 1 mg given two or three times daily 1. The guidelines from the ACC/AHA also list prazosin's usual dose range as 2-20 mg daily, given 2 or 3 times per day, with no mention of sub-1 mg formulations 2, 3.

Research Context on Lower Doses

While standard commercial formulations don't exist below 1 mg, research studies have investigated lower doses:

  • 0.5-1 mg daily was used successfully in a depression/trauma study, showing efficacy with mild-to-moderate orthostatic hypotension as the main adverse effect 4
  • 0.25-1 mg doses were studied in hemodialysis patients for muscle cramps 5
  • 0.5 mg initial dose was used in a pharmacokinetic study examining blood pressure response 6

These lower doses were likely achieved through compounding or splitting tablets for research purposes, not through commercially available formulations.

Clinical Implications

If you need a dose lower than 1 mg, you would need to:

  • Have the medication compounded by a specialty pharmacy
  • Consider splitting the 1 mg capsule (though this is not ideal for capsule formulations)
  • Start with the standard 1 mg dose and monitor closely for first-dose hypotension

The guidelines specifically warn about orthostatic hypotension with alpha-1 blockers, especially in older adults 2, 3. The FDA labeling emphasizes the importance of the initial 1 mg dose to minimize first-dose syncope risk 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.